Document ID: chunk:federal_register_of_legislation:F2024C01192:front:0:p2
Version: federal_register_of_legislation:F2024C01192
Segment Type: other
Provision Reference: 
Character Range: 2912–5903

may be supplied without a prescription by an approved pharmacist – pharmaceutical benefits that have certain listed drugs
Endnotes
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history

Part 1—Preliminary

1.01  Name
 (1) This instrument is the National Health (Continued Dispensing) Determination 2022.
 (2) This instrument may also be cited as PB 59 of 2022.

1.03  Authority
  This instrument is made under subsection 89A(3) of the National Health Act 1953.

1.05  Definitions
 (1) In this instrument:
Act means the National Health Act 1953.
electronic prescription has the meaning given by subsection 5(1) of the Regulations.
increased maximum quantity, for a pharmaceutical item, means a quantity or number of units that has been determined under paragraph 85A(2)(a) of the Act as the maximum quantity or number of units of the pharmaceutical item in the pharmaceutical benefit that may, for a relevant purpose, be directed in a prescription to be supplied on any one occasion.
patient: see subsection 3.01(1).
purposes code has the meaning given by the National Health (Listing of Pharmaceutical Benefits) Instrument 2024.
Regulations means the National Health (Pharmaceutical Benefits) Regulations 2017.
relevant purpose, for a pharmaceutical benefit, means a purpose, mentioned in Part 1 of Schedule 4 of the National Health (Listing of Pharmaceutical Benefits) Instrument 2024 for a purposes code specified in Schedule 1 of that instrument for the pharmaceutical benefit, that includes the phrase "The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient".
requested supply: see subsection 3.01(1).
 (2) Where an expression that is used in this instrument is defined for the purposes of Part VII of the Act, it has the same meaning in this instrument as it has in that Part. Expressions used in this instrument that are defined in Part VII include the following:
 (a) approved pharmacist;
 (b) pbs prescriber;
 (c) pharmaceutical benefit has a drug;
 (d) pharmaceutical benefit;
 (e) pharmaceutical item;
 (f) schedule equivalent.

1.06  Purpose
  The purpose of this instrument is to determine:
 (a) the pharmaceutical benefits that may be supplied by an approved pharmacist without a prescription; and
 (b) the conditions that must be satisfied when making a supply of those pharmaceutical benefits.

Part 2—Pharmaceutical benefits that may be supplied without a prescription

2.01  Pharmaceutical benefits covered by this instrument
  For the purposes of paragraph 89A(3)(a) of the Act, each pharmaceutical benefit that has a drug mentioned in an item in Schedule 1 is determined to be a pharmaceutical benefit that may be supplied by an approved pharmacist without a prescription.
Note: A pharmaceutical benefit has the drug or medicinal preparation referred to in paragraph (a) of the definition pharmaceutical benefit in relation to that